| For: | Liu M, Ji YL, Hu YJ, Su YX, Yang J, Wang XY, Chu HY, Zhang X, Dong SJ, Yang H, Liu YH, Zhou SM, Guo LP, Ran Y, Li YN, Zhao JW, Zhang ZG, Piao MY, Zhou L. Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption. World J Gastroenterol 2025; 31(10): 101014 [PMID: 40093673 DOI: 10.3748/wjg.v31.i10.101014] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i10/101014.htm |
| Number | Citing Articles |
| 1 |
Vladimir Ivashkin, Elena Shirokova, Yury Zharikov, Alexey Sigidaev, Oksana Zolnikova, Elena Poluektova, Roman Maslennikov, Yana Kiseleva. Microbiome-immune interactions in autoimmune liver diseases. World Journal of Gastroenterology 2026; 32(12): 115853 doi: 10.3748/wjg.v32.i12.115853
|
| 2 |
Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip B. Hylemon. Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities. Pharmacological Reviews 2026; 78(2) doi: 10.1016/j.pharmr.2026.100120
|
| 3 |
Chen Lin, Yu-Wei Mi, Huo-Wang Zheng, Yan-Bin Hou, Jie-Qiong Hu, Jia-Xin Mao, Ni Dai, Chao-Lang Fu, Xiao-Qiong Li, Yun-Xin Ji. Effects of in vitro fermentation of Astragalus polysaccharide on gut microbiota and neurotransmitter metabolites in patients with major depressive disorder. Frontiers in Psychiatry 2026; 17 doi: 10.3389/fpsyt.2026.1752933
|
| 4 |
Ren Qianlang, Zhao Yanxin, Xiong Dejia, Wang Guoqing, Lu Lihong, Chen Hang, Wang Xianmei, Lv Junyan, Ma Lanqing. Gut microbiota alterations in primary biliary cholangitis: a systematic review and meta-analysis. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1847865
|